Hang Seng Indexes Company: Hang Seng Hong Kong and US Technology Index to Include SpaceX
SpaceX is set to be included in the Hang Seng Hong Kong and US Technology Index following its planned IPO in June 2026. The index provider will recalculate the weighting of its US-listed constituents to equal weight after SpaceX's eleventh trading day, with the changes taking effect on June 29, 2026. Separately, Shanghai Pharmaceuticals announced its subsidiary received approval for Roxadustat capsules, a treatment for anemia associated with chronic kidney disease, with an estimated market value of 2.593 billion yuan in mainland China hospitals for 2025. AI
IMPACT SpaceX's IPO and index inclusion may influence tech sector investment, while Shanghai Pharma's drug approval highlights advancements in medical treatments.